Abstract:
The pharmaceutical industry in Bangladesh has emerged as a highly advanced technology sector, boasting 67 years of medical and scientific expertise. Manufacturers in the country produce a wide range of pharmaceuticals, including insulin, hormones, and anti-cancer drugs. This industry efficiently caters to 97% of the local market's pharmaceutical needs and has also expanded its reach to global markets, including Europe. With approximately 5,600 brands of medicines available in various dosage forms, Bangladesh's pharmaceutical sector demonstrates its significant contribution to the country's economy.
Moreover, Bangladesh had 1,495 wholesale drug license holders and around 37,700 retail drug license holders, reflecting the industry's robust presence. Owing to recent advancements, pharmaceutical exports from Bangladesh have extended to 79 countries, encompassing active pharmaceutical ingredients (APIs) and a diverse range of drugs across major treatment classes and dosage forms. In addition to conventional products like tablets, capsules, and syrups, the country also exports specialized items such as HFA inhalers, CFC inhalers, suppositories, nasal drops, and injectable intravenous infusions. These offerings enjoy popularity among doctors, pharmacists, patients, and regulators in the importing countries. The growth and success of Bangladesh's pharmaceutical industry are evident in its thriving domestic market and expanding global presence.
